News

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Q2 2025 Management View CEO Steven A. Cutler highlighted an 11% sequential increase in gross business awards over quarter 1, driven by wins from biotech customers and ongoing expansion in large pharma ...